UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors

Molecules (Basel, Switzerland), 2023-02, Vol.28 (4), p.1984

2023

Link zum Volltext

Verfügbarkeit prüfen

Kojic Acid Derivatives as Histamine H3 Receptor Ligands

Chemical and Pharmaceutical Bulletin, 2010/10/01, Vol.58(10), pp.1353-1361

2010

Link zum Volltext

Verfügbarkeit prüfen

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ

Frontiers in pharmacology, 2019-03, Vol.10, p.263-263

2019

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands

Frontiers in chemistry, 2017-09, Vol.5

2017

Link zum Volltext

Verfügbarkeit prüfen

First Metal-Containing Histamine H3 Receptor Ligands

Organic letters, 2010-06, Vol.12 (11), p.2578-2581

2010

Link zum Volltext

Verfügbarkeit prüfen

Second-Generation Dual FXR/sEH Modulators with Optimized Pharmacokinetics

Journal of medicinal chemistry, 2021-07, Vol.64 (13), p.9525-9536

2021

Link zum Volltext

Verfügbarkeit prüfen

A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis

Journal of medicinal chemistry, 2017-09, Vol.60 (18), p.7703-7724

2017

Link zum Volltext

Verfügbarkeit prüfen

Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties

European journal of medicinal chemistry, 2014-04, Vol.77, p.269-279

2014

Link zum Volltext

Verfügbarkeit prüfen

Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology

Journal of medicinal chemistry, 2018-07, Vol.61 (13), p.5758-5764

2018

Link zum Volltext

Verfügbarkeit prüfen

Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H 3/H 4 receptor ligands

European journal of pharmacology, 2011-03, Vol.654 (3), p.200-208

2011

Link zum Volltext

Verfügbarkeit prüfen

Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases

European journal of medicinal chemistry, 2022-01, Vol.228, p.113975-113975, Article 113975

2022

Link zum Volltext

Verfügbarkeit prüfen

N -Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases

Journal of medicinal chemistry, 2022-03, Vol.65 (5), p.3913-3922

2022

Link zum Volltext

Verfügbarkeit prüfen

Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H₃/H₄ receptor ligands

European journal of pharmacology, 2011-03, Vol.654 (3), p.200-208

2011

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Structure–Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5‑Lipoxygenase

Journal of medicinal chemistry, 2020-10, Vol.63 (20), p.11498-11521

2020

Link zum Volltext

Verfügbarkeit prüfen

Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator

Journal of medicinal chemistry, 2021-03, Vol.64 (5), p.2815-2828

2021

Link zum Volltext

Verfügbarkeit prüfen

Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores

European journal of medicinal chemistry, 2020-01, Vol.185, p.111766-111766, Article 111766

2020

Link zum Volltext

Verfügbarkeit prüfen

RhII‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors

ChemMedChem, 2021-11, Vol.16 (22), p.3410-3417

2021

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors

Journal of medicinal chemistry, 2021-12, Vol.64 (23), p.17259-17276

2021

Link zum Volltext

Verfügbarkeit prüfen

Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese Mice

ACS pharmacology & translational science, 2021-04, Vol.4 (2), p.966-979

2021

Link zum Volltext

Verfügbarkeit prüfen

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast

ChemMedChem, 2020-01, Vol.15 (1), p.50-67

2020

Link zum Volltext

Verfügbarkeit prüfen

N‑Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators

Journal of medicinal chemistry, 2016-01, Vol.59 (1), p.61-81

2016

Link zum Volltext

Verfügbarkeit prüfen

Rh II -Catalyzed De-symmetrization of Ethane-1,2-dithiol and Propane-1,3-dithiol Yields Metallo-β-lactamase Inhibitors

ChemMedChem, 2021-11, Vol.16 (22), p.3410-3417

2021

Link zum Volltext

Verfügbarkeit prüfen

Cover Feature: Rh II ‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors (ChemMedChem 22/2021)

ChemMedChem, 2021-11, Vol.16 (22), p.3375-3375

2021

Link zum Volltext

Verfügbarkeit prüfen

Cover Feature: RhII‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors (ChemMedChem 22/2021)

ChemMedChem, 2021-11, Vol.16 (22), p.3375-3375

2021

Link zum Volltext

Verfügbarkeit prüfen

2,4-Diaminopyrimidines as histamine H 4 receptor ligands—Scaffold optimization and pharmacological characterization

Bioorganic & medicinal chemistry, 2009-10, Vol.17 (20), p.7186-7196

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(52)

Sprache

Englisch
(51)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Humans
(20)
Pharmacology & Pharmacy
(19)
Chemistry, Medicinal
(17)
Structure-Activity Relationship
(15)
Ligands
(12)
Chemistry
(11)
Animals
(10)
Molecular Structure
(9)
Histamine
(8)
Receptors, Histamine H3 - Metabolism
(8)
Dose-Response Relationship, Drug
(7)
Epoxide Hydrolases - Antagonists & Inhibitors
(6)
Drug Design
(5)
Enzyme Inhibitors - Pharmacology
(5)
Epoxide Hydrolases - Metabolism
(5)
Gpcr
(5)
Mice
(5)
Physical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors

Kojic Acid Derivatives as Histamine H3 Receptor Ligands

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ

Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands

First Metal-Containing Histamine H3 Receptor Ligands

Second-Generation Dual FXR/sEH Modulators with Optimized Pharmacokinetics

A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis

Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties

Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology

Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H 3/H 4 receptor ligands

Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases

N -Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases

Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H₃/H₄ receptor ligands

Design, Synthesis, and Structure–Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5‑Lipoxygenase

Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator

Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores

RhII‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors

Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors

Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese Mice

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast

N‑Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators

Rh II -Catalyzed De-symmetrization of Ethane-1,2-dithiol and Propane-1,3-dithiol Yields Metallo-β-lactamase Inhibitors

Cover Feature: Rh II ‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors (ChemMedChem 22/2021)

Cover Feature: RhII‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors (ChemMedChem 22/2021)

2,4-Diaminopyrimidines as histamine H 4 receptor ligands—Scaffold optimization and pharmacological characterization

Suchergebnisse filtern